Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial.
Torsten O NielsenSamuel C Y LeungNazia RiazAnna Marie MulliganZuzana KosAnita BaneTimothy J WhelanPublished in: Histopathology (2023)
ClinicalTrials.gov number, NCT01791829.